These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 21443960)
21. A phase IIa, randomized, double-blind, safety, immunogenicity and efficacy trial of Plasmodium falciparum vaccine antigens merozoite surface protein 1 and RTS,S formulated with AS02 adjuvant in healthy, malaria-naïve adults. Cummings JF; Polhemus ME; Kester KE; Ockenhouse CF; Gasser RA; Coyne P; Wortmann G; Nielsen RK; Schaecher K; Holland CA; Krzych U; Tornieporth N; Soisson LA; Angov E; Heppner DG; Vaccine; 2024 Apr; 42(12):3066-3074. PubMed ID: 38584058 [TBL] [Abstract][Full Text] [Related]
22. Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic region. Abdulla S; Salim N; Machera F; Kamata R; Juma O; Shomari M; Kubhoja S; Mohammed A; Mwangoka G; Aebi T; Mshinda H; Schellenberg D; Carter T; Villafana T; Dubois MC; Leach A; Lievens M; Vekemans J; Cohen J; Ballou WR; Tanner M Malar J; 2013 Jan; 12():11. PubMed ID: 23297680 [TBL] [Abstract][Full Text] [Related]
23. Protective efficacy of the RTS,S/AS02 Plasmodium falciparum malaria vaccine is not strain specific. Alloueche A; Milligan P; Conway DJ; Pinder M; Bojang K; Doherty T; Tornieporth N; Cohen J; Greenwood BM Am J Trop Med Hyg; 2003 Jan; 68(1):97-101. PubMed ID: 12556156 [TBL] [Abstract][Full Text] [Related]
24. Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. Lalvani A; Moris P; Voss G; Pathan AA; Kester KE; Brookes R; Lee E; Koutsoukos M; Plebanski M; Delchambre M; Flanagan KL; Carton C; Slaoui M; Van Hoecke C; Ballou WR; Hill AV; Cohen J J Infect Dis; 1999 Nov; 180(5):1656-64. PubMed ID: 10515829 [TBL] [Abstract][Full Text] [Related]
25. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A. Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial. Macete EV; Sacarlal J; Aponte JJ; Leach A; Navia MM; Milman J; Guinovart C; Mandomando I; López-Púa Y; Lievens M; Owusu-Ofori A; Dubois MC; Cahill CP; Koutsoukos M; Sillman M; Thompson R; Dubovsky F; Ballou WR; Cohen J; Alonso PL Trials; 2007 Mar; 8():11. PubMed ID: 17386091 [TBL] [Abstract][Full Text] [Related]
27. A randomized trial assessing the safety and immunogenicity of AS01 and AS02 adjuvanted RTS,S malaria vaccine candidates in children in Gabon. Lell B; Agnandji S; von Glasenapp I; Haertle S; Oyakhiromen S; Issifou S; Vekemans J; Leach A; Lievens M; Dubois MC; Demoitie MA; Carter T; Villafana T; Ballou WR; Cohen J; Kremsner PG PLoS One; 2009 Oct; 4(10):e7611. PubMed ID: 19859560 [TBL] [Abstract][Full Text] [Related]
28. Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial. Thera MA; Doumbo OK; Coulibaly D; Laurens MB; Kone AK; Guindo AB; Traore K; Sissoko M; Diallo DA; Diarra I; Kouriba B; Daou M; Dolo A; Baby M; Sissoko MS; Sagara I; Niangaly A; Traore I; Olotu A; Godeaux O; Leach A; Dubois MC; Ballou WR; Cohen J; Thompson D; Dube T; Soisson L; Diggs CL; Takala SL; Lyke KE; House B; Lanar DE; Dutta S; Heppner DG; Plowe CV PLoS One; 2010 Feb; 5(2):e9041. PubMed ID: 20140214 [TBL] [Abstract][Full Text] [Related]